Thu.Oct 22, 2020

Sarepta, continuing its gene therapy push, helps launch a startup

Bio Pharma Dive

The biotech has joined a group of investors to form a new gene therapy developer led by one of its longtime executives and backed with $107 million

Pharma managers too far removed from patients

World of DTC Marketing

As people move up the pharma ladder, their work often revolves around internal management issues, training, and endless meetings to motivate their employees rather than focus on patients. Pharma likes to believe its own propaganda that everything they do is patient-focused, but that’s a canard.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Gilead's Veklury becomes first FDA-approved drug for COVID-19

Bio Pharma Dive

The U.S. regulator granted a full approval after allowing emergency use earlier this year. New results from an WHO study, however, raise questions about the drug's ultimate effectiveness

Research to bring more secure software for autonomous battlefield operations


Credit: U.S. Army Operational Test Command photo/Tad Browning WEST LAFAYETTE, Ind. — Drones and other unmanned machines can save human lives on the battlefield, but adversaries could hack into their artificial intelligence software.

Facing vaccine doubts, US grapples with building confidence in coronavirus shots

Bio Pharma Dive

The CDC, for example, doesn't support vaccine mandates for healthcare workers or essential employees, an agency official told experts convened by the FDA Thursday

Toxic positivity and grief: The reality of living through cancer

Pharma Phorum

Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase. No one gets through cancer unscathed. People are usually left with a mixture of treatment aftereffects, toxic positivity, and lingering anger to deal with.

More Trending

Mixing Branded and Unbranded on One Page—Is it Worth the Risk?

Pharma Marketing Network

A marketer’s decision to take one promotional route over another—branded versus unbranded—is often critical. But what we increasingly see, is that when branded and unbranded ads appear on the same page—a company page on Facebook, a third-party web publisher, a blogger, etc.—the

Roche joins the COVID-19 antiviral drug race, betting $350M on a startup

Bio Pharma Dive

A deal with Atea Pharmaceuticals gives Roche rights to an oral antiviral for coronavirus disease that would compete with emerging therapies from Pfizer and Merck

Drugs 197

Ancient Maya built sophisticated water filters


Maya imported zeolite and quartz to filter drinking water Credit: David Lentz Ancient Maya in the once-bustling city of Tikal built sophisticated water filters using natural materials they imported from miles away, according to the University of Cincinnati.

Lilly hires consultant to help fix issues at COVID-19 drug manufacturing plant

Bio Pharma Dive

The New Jersey facility that ran afoul of FDA manufacturing standards is one of several Lilly is using to produce coronavirus antibody drugs

FDA Greenlights Restart of AstraZeneca’s Phase III COVID-19 Vaccine Study


After nearly a month in limbo, AstraZeneca will resume Phase III testing of its COVID-19 vaccine candidate in the United States

Using Behavioral Science in A Digital World

Pharma Mirror

By Rotem Shor, Medisafe Chief Technology Officer Technology and health have experienced a convergence in the last few years, leading to a new state of digital health that is transforming how we live and work.


Novartis Sees Glimmer of Hope for Branaplam in Huntington’s Disease


After discovering promising indicators on the path to the development of Branaplam (LMIO70) for spinal muscular atrophy, Novartis now hopes to repurpose the drug for the treatment of Hungtington’s disease

Drugs 102

Do the twist: Making two-dimensional quantum materials using curved surfaces


Credit: Image courtesy of Song Jin Lab MADISON, Wis. — Scientists at the University of Wisconsin-Madison have discovered a way to control the growth of twisting, microscopic spirals of materials just one atom thick.

FDA COVID-19 Vaccine Advisory Committee: Lots of Talk, No Decisions, Some Reassurance


In the meeting, both the FDA and the U.S. Centers for Disease Control and Prevention presented details about COVID-19 and the requirements for a vaccine

Researchers develop simple way to capture high quality 3d images of live cells and organisms


New approach captures multifocus microscopy images with high speeds Credit: Sheng Xiao, Boston University WASHINGTON — Researchers have developed a simple method for simultaneously acquiring images at different depths with a standard microscope.

Catalent Boosts Supply Chain Transparency in Response to COVID-19 Manufacturing Urgency


The pharmaceutical supply chain is being pushed to its limit as it prepares to deliver COVID-19 vaccines and therapeutics to the entire world as soon as possible, while continuing to produce and deliver all the usual medications and products

NIH award to fuse immunology and neuroscience research


Credit: Virginia Tech Gabriela Carrillo didn’t always aspire to be a neuroscientist. It wasn’t until she was providing in-home behavioral analysis therapy for children with autism that she was drawn to the lab.

New patent expiration for Celgene drug THALOMID

Drug Patent Watch

Annual Drug Patent Expirations for THALOMID Thalomid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are nine patents protecting…. The post New patent expiration for Celgene drug THALOMID appeared first on DrugPatentWatch - Make Better Decisions.

COVID-19 infection may be part of a ‘perfect storm’ for Parkinson’s disease


Credit: Courtesy of Trends in Neurosciences GRAND RAPIDS, Mich. 22, 2020) — Can COVID-19 infection increase the risk of developing Parkinson’s disease?

Retrophin Buys Orphan Technologies for $517 Million to Gain Enzyme Replacement Therapy


OT-58 is Orphan’s novel investigational enzyme replacement therapy. It is currently in Phase I/II development for classical HCU, a rare metabolic disorder marked by increased levels of plasma homocysteine

A wearable sensor to help ALS patients communicate


Researchers have designed a skin-like device that can measure small facial movements in patients who have lost the ability to speak. Credit: David Sadat CAMBRIDGE, MA — People with amyotrophic lateral sclerosis (ALS) suffer from a gradual decline in their ability to control their muscles.

Hope for Primary Hyperoxaluria: Alnylam Shares Positive Trial Results


Two Phase III studies showed significant reduction in urinary oxalate excretion in patients of all ages with PH1

Grafting with epigenetically-modified rootstock yields surprise


Progeny of novel combination is more vigorous and productive than parental plants Credit: Penn State UNIVERSITY PARK, Pa.

Sarepta helps bankroll new gene therapy startup AavantiBio

Pharma Phorum

Sarepta chief commercial officer Bo Cumbo has left to head up gene therapy venture – AavantiBio – with $107 million in backing from his former employer and three high-profile life sciences investors.

DNA in fringe-lipped bat poop reveals unexpected eating habits


Credit: Illustration by Amy Koehler Poop is full of secrets. For scientists, digging into feces provides insights into animal diets and is particularly useful for understanding nocturnal or rare species.

DNA 60

New research opens up gene therapy for a wider range of degenerative retinal diseases

BioPharma Reporter

Scientists have used gene therapy and a newly developed light-sensing protein to restore sight in mice: with the technology to start clinical trials in the US later this year. Bio Developments

New PETA grant honors EPA administrator


Wheeler Scholarship will help scientists develop non-animal test methods Credit: PETA Washington — For preventing countless animals from being used in chemical tests, U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler is being honored by the creation of the Pat C.

New patent expiration for Celgene drug POMALYST

Drug Patent Watch

Annual Drug Patent Expirations for POMALYST Pomalyst is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…. The post New patent expiration for Celgene drug POMALYST appeared first on DrugPatentWatch - Make Better Decisions.

Research shows aging chimps, like humans, value friendships


Credit: University of New Mexico Old friends get together to relax, share meals, and trust and support each other. In the latter part of life, these friendships are highly valued. Recent research shows this happens in chimpanzees as well as humans.

New patent expiration for Celgene drug REVLIMID

Drug Patent Watch

Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are twenty patents protecting…. The post New patent expiration for Celgene drug REVLIMID appeared first on DrugPatentWatch - Make Better Decisions.

NRL researchers evaluate ultraviolet sources, combat COVID-19


Credit: U.S. Navy photo by Jonathan Steffen WASHINGTON – U.S.

New patent for Rvl Pharms drug UPNEEQ

Drug Patent Watch

Annual Drug Patent Expirations for UPNEEQ Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are two patents protecting this drug. This drug has…. The post New patent for Rvl Pharms drug UPNEEQ appeared first on DrugPatentWatch - Make Better Decisions. Patent Added

Comparing the promise and reality of e-scooters


A critical assessment of equity improvements and mode-shift Credit: Michael McQueen Is shared micromobility the ideal first/last mile supplement to transit? Can electric scooters make it easier for historically disadvantaged populations to get around?